Upgrades
- Continental Resources (CLR) upgraded by KeyBanc from Sector Weight to Overweight
Downgrades
- Arcturus Therapeutics (ARCT) downgraded by Baird from Outperform to Neutral
- Arcturus Therapeutics (ARCT) downgraded by Barclays from Overweight to Equal Weight
- Arcturus Therapeutics (ARCT) downgraded by Raymond James from Outperform to Market Perform
- Aprea Therapeutics (APRE) downgraded by Baird from Outperform to Neutral
- Fujitsu General (FGELF) downgraded by JPMorgan from Overweight to Neutral
It's clear there are powerful headwinds for NVDA in 2025. The world's biggest hedge fund is selling their shares and Amazon's Jeff Bezos is investing millions into a new Nvidia rival... Analysts on and off Wall Street say to load up on THIS ticker instead.
Upgrades & Downgrades provided by The Fly at http://www.thefly.com. The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.